• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便银行用于粪便微生物群移植:大型粪便银行的方法和操作。

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank.

机构信息

OpenBiome, Cambridge, MA, United States.

出版信息

Front Cell Infect Microbiol. 2021 Apr 15;11:622949. doi: 10.3389/fcimb.2021.622949. eCollection 2021.

DOI:10.3389/fcimb.2021.622949
PMID:33937092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8082449/
Abstract

OBJECTIVES

Fecal microbiota transplantation (FMT) is a recommended therapy for recurrent infection and is being investigated as a potential therapy for dozens of microbiota-mediated indications. Stool banks centralize FMT donor screening and FMT material preparation with the goal of expanding access to FMT material while simultaneously improving its safety, quality, and convenience. Although there are published consensuses on donor screening guidelines, there are few reports about the implementation of those guidelines in functioning stool banks.

METHODS

To help inform consensus standards with data gathered from real-world settings and, in turn, to improve patient care, here we describe the general methodology used in 2018 by OpenBiome, a large stool bank, and its outputs in that year.

RESULTS

In 2018, the stool bank received 7,536 stool donations from 210 donors, a daily average of 20.6 donations, and processed 4,271 of those donations into FMT preparations. The median time a screened and enrolled stool donor actively donated stool was 5.8 months. The median time between the manufacture of an FMT preparation and its shipment to a hospital or physician was 8.9 months. Half of the stool bank's partner hospitals and physicians ordered an average of 0.75 or fewer FMT preparations per month.

CONCLUSIONS

Further knowledge sharing should help inform refinements of stool banking guidelines and best practices.

摘要

目的

粪便微生物群移植(FMT)是复发性感染的推荐疗法,并且正在作为数十种微生物群介导的适应证的潜在疗法进行研究。粪便库集中了 FMT 供体筛查和 FMT 材料准备,目的是扩大 FMT 材料的获取途径,同时提高其安全性、质量和便利性。尽管有关于供体筛查指南的已发表共识,但关于这些指南在运行中的粪便库中的实施情况的报告很少。

方法

为了帮助用来自真实环境的数据制定共识标准,并进而改善患者护理,我们在此描述了 2018 年大型粪便库 OpenBiome 使用的一般方法及其当年的结果。

结果

2018 年,该粪便库从 210 位供体中收到了 7536 份粪便捐赠,平均每天 20.6 份,其中 4271 份经过处理制成 FMT 制剂。经过筛选并注册的供体积极捐赠粪便的中位时间为 5.8 个月。FMT 制剂生产和运往医院或医生的中位时间为 8.9 个月。该粪便库一半的合作医院和医生平均每月订购的 FMT 制剂少于或等于 0.75 份。

结论

进一步的知识共享应有助于完善粪便库管理指南和最佳实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/11d4babdbb7d/fcimb-11-622949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/e0f7a76da9ad/fcimb-11-622949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/5948a934a6ca/fcimb-11-622949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/9e22afa1bbb9/fcimb-11-622949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/7e5fb3460fef/fcimb-11-622949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/11d4babdbb7d/fcimb-11-622949-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/e0f7a76da9ad/fcimb-11-622949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/5948a934a6ca/fcimb-11-622949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/9e22afa1bbb9/fcimb-11-622949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/7e5fb3460fef/fcimb-11-622949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e6/8082449/11d4babdbb7d/fcimb-11-622949-g005.jpg

相似文献

1
Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank.粪便银行用于粪便微生物群移植:大型粪便银行的方法和操作。
Front Cell Infect Microbiol. 2021 Apr 15;11:622949. doi: 10.3389/fcimb.2021.622949. eCollection 2021.
2
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
3
How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.如何为应对持续的 COVID-19 大流行做好粪便库的准备:荷兰的经验以及粪菌移植的回顾性对照队列研究。
PLoS One. 2022 Mar 17;17(3):e0265426. doi: 10.1371/journal.pone.0265426. eCollection 2022.
4
Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.建立用于治疗艰难梭菌感染的粪便微生物群移植服务。
Clin Infect Dis. 2016 Apr 1;62(7):908-14. doi: 10.1093/cid/civ994. Epub 2015 Nov 30.
5
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study.以直接粪便检测为基础的策略进行粪便微生物群移植供体筛查:一项前瞻性队列研究。
Microbes Infect. 2024 Jul-Aug;26(5-6):105341. doi: 10.1016/j.micinf.2024.105341. Epub 2024 Apr 26.
6
A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.中国粪便微生物群移植中粪便供体筛查的综合方法。
Microb Cell Fact. 2021 Nov 27;20(1):216. doi: 10.1186/s12934-021-01705-0.
7
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.粪便银行用于粪便微生物群移植的标准化模型:多学科 UEG 工作组的共识报告。
United European Gastroenterol J. 2021 Mar;9(2):229-247. doi: 10.1177/2050640620967898. Epub 2021 Mar 9.
8
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.用于复发性艰难梭菌感染的粪便微生物群移植供体及粪便样本的实验室检测
J Clin Microbiol. 2017 Apr;55(4):1002-1010. doi: 10.1128/JCM.02327-16. Epub 2017 Jan 11.
9
Faecal microbiota transplantation for infection: Four years' experience of the Netherlands Donor Feces Bank.粪便微生物群移植治疗 感染:荷兰供体粪便银行四年经验。
United European Gastroenterol J. 2020 Dec;8(10):1236-1247. doi: 10.1177/2050640620957765. Epub 2020 Sep 29.
10
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.

引用本文的文献

1
Donor-centric administration of the stool donor program is vital to its feasibility and patient safety.以供体为中心管理粪便供体计划对其可行性和患者安全至关重要。
Gut Microbes. 2025 Dec;17(1):2508950. doi: 10.1080/19490976.2025.2508950. Epub 2025 Jun 18.
2
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.粪菌移植治疗复发性艰难梭菌感染及其全球监管格局。
Indian J Med Res. 2025 Feb;161(2):113-119. doi: 10.25259/IJMR_818_2024.
3
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome.

本文引用的文献

1
Fecal Microbiota Transplantation "Donor Effects" Are Not Clinically Relevant for Clostridioides difficile Infection.粪便微生物群移植的“供体效应”与艰难梭菌感染的临床情况无关。
Gastroenterology. 2021 Jun;160(7):2635-2636. doi: 10.1053/j.gastro.2020.12.057. Epub 2020 Dec 30.
2
Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation.粪便处理速度和储存时间不影响粪便微生物群移植的临床效果。
Gut Microbes. 2020 Nov 1;11(6):1806-1808. doi: 10.1080/19490976.2020.1768777. Epub 2020 Jun 18.
3
How do I establish a stool bank for fecal microbiota transplantation within the blood- and tissue transplant service?
在学术癌症中心网络中实施团队科学以揭示肠道微生物组的结构与功能。
J Clin Med. 2025 Mar 17;14(6):2040. doi: 10.3390/jcm14062040.
4
Prolonged storage reduces viability of and core intestinal bacteria in fecal microbiota transplantation preparations for dogs.长时间储存会降低用于犬类的粪便微生物群移植制剂中活的核心肠道细菌数量。
Front Microbiol. 2025 Jan 7;15:1502452. doi: 10.3389/fmicb.2024.1502452. eCollection 2024.
5
Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy.粪便微生物群移植治疗青光眼;一种潜在的新兴治疗策略。
Curr Res Microb Sci. 2024 Nov 13;7:100314. doi: 10.1016/j.crmicr.2024.100314. eCollection 2024.
6
Fecal Microbiota Transplantation: Indications, Methods, and Challenges.粪便微生物群移植:适应症、方法及挑战
J Microbiol. 2024 Dec;62(12):1057-1074. doi: 10.1007/s12275-024-00184-3. Epub 2024 Nov 18.
7
Knowledge and perceptions of South African blood donors towards biobanking and stool donation.南非献血者对生物样本库和粪便捐献的认知与看法。
S Afr J Infect Dis. 2024 Oct 31;39(1):645. doi: 10.4102/sajid.v39i1.645. eCollection 2024.
8
Evaluation of Bacterial Viability for Fecal Microbiota Transplantation: Impact of Thawing Temperature and Storage Time.粪便微生物群移植中细菌活力的评估:解冻温度和储存时间的影响
Microorganisms. 2024 Jun 25;12(7):1294. doi: 10.3390/microorganisms12071294.
9
Economic and Chronologic Optimization of Fecal Donors Screening Process.粪便捐献者筛查流程的经济与时间优化
MDM Policy Pract. 2024 Jun 13;9(1):23814683241254809. doi: 10.1177/23814683241254809. eCollection 2024 Jan-Jun.
10
Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China.粪便微生物群移植捐赠者的经历与态度:一项来自中国的实证性生物伦理学研究。
Imeta. 2022 Nov 21;1(4):e62. doi: 10.1002/imt2.62. eCollection 2022 Dec.
我如何在血液和组织移植服务范围内建立用于粪便微生物群移植的粪便库?
Transfusion. 2020 Jun;60(6):1135-1141. doi: 10.1111/trf.15816. Epub 2020 May 28.
4
Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of infection.首个将粪便微生物群移植用作治疗感染的药用产品的英国粪便库的结果。
EClinicalMedicine. 2020 Mar 16;20:100301. doi: 10.1016/j.eclinm.2020.100301. eCollection 2020 Mar.
5
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
6
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.2019冠状病毒病疫情期间粪便微生物群移植供体的筛查:国际专家小组提出的紧急更新建议
Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17.
7
Global disparities in faecal microbiota transplantation research.粪便微生物群移植研究中的全球差异
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):241. doi: 10.1016/S2468-1253(19)30452-2.
8
Regulatory Considerations for Fecal Microbiota Transplantation Products.粪便微生物群移植产品的监管考虑因素。
Cell Host Microbe. 2020 Feb 12;27(2):173-175. doi: 10.1016/j.chom.2020.01.018.
9
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.澳大利亚共识声明:临床实践中粪便微生物群移植的监管、生产和使用。
Gut. 2020 May;69(5):801-810. doi: 10.1136/gutjnl-2019-320260. Epub 2020 Feb 11.
10
Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.了解 DIY 粪便微生物群移植的范围。
Am J Gastroenterol. 2020 Apr;115(4):603-607. doi: 10.14309/ajg.0000000000000499.